Chargement en cours...
Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients
INTRODUCTION: Second-generation H1-antihistamines (SGAHs) are the mainstay of treatment of chronic spontaneous urticaria (CSU). Bilastine, newer non-sedating SGAHs, was recently introduced in India after the approval of the Drugs Controller General of India. There is a paucity of evidence about the...
Enregistré dans:
| Publié dans: | Indian J Dermatol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer - Medknow
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208247/ https://ncbi.nlm.nih.gov/pubmed/34188271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_771_20 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|